Chile - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Chile Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 22.7% year on year. With 64 Cases in 2019, the country was ranked number 167 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 64.00
2018 62.00
2017 37.00
2016 30.00
2015 30.00
Download all data from 2005 to 2019

How does Chile rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
167 #167
Burundi
64 2019 +28.0 % +5.9 % View data
167 #167
Chile
64 2019 +3.2 % +22.7 % View data
170 #170
Gabon
63 2019 -28.4 % +1.3 % View data
Compare all 359 countries

Go Top